| Followers | 86 |
| Posts | 8196 |
| Boards Moderated | 0 |
| Alias Born | 06/17/2013 |
Tuesday, June 23, 2020 4:47:05 AM
ADVFN_curncman,
I've been reading up this morning on dendritic cells , and
found this while doing my DD :
https://therapeuticsolutionsint.com/patent-abstracts/
Treatment of SARS-CoV-2 with Dendritic Cells for Innate and/or Adaptive Immunity
Disclosed are means, methods, and compositions of matter for prophylaxis and/or treatment of SARS-CoV-2 by administration of dendritic cells in a manner and frequency sufficient to induce activation of innate and/or adaptive immune responses. In one embodiment the invention teaches administration of dendritic cells pulsed with one or more innate immune stimulants in a manner endowing said dendritic cell with ability to induce augmentation of natural killer (NK) cell number and/or activity. In another embodiment the invention teaches the use of dendritic cells stimulated with innate immune activators in a manner to allow for uptake of viral particles and presentation of viral epitopes to T cells in order to stimulate immunological activation and/or memory responses.
I've been reading up this morning on dendritic cells , and
found this while doing my DD :
https://therapeuticsolutionsint.com/patent-abstracts/
Treatment of SARS-CoV-2 with Dendritic Cells for Innate and/or Adaptive Immunity
Disclosed are means, methods, and compositions of matter for prophylaxis and/or treatment of SARS-CoV-2 by administration of dendritic cells in a manner and frequency sufficient to induce activation of innate and/or adaptive immune responses. In one embodiment the invention teaches administration of dendritic cells pulsed with one or more innate immune stimulants in a manner endowing said dendritic cell with ability to induce augmentation of natural killer (NK) cell number and/or activity. In another embodiment the invention teaches the use of dendritic cells stimulated with innate immune activators in a manner to allow for uptake of viral particles and presentation of viral epitopes to T cells in order to stimulate immunological activation and/or memory responses.
Recent TSOI News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/24/2025 10:05:30 AM
